Deep brain stimulation can help reduce tremors in MS patients without causing new flare-ups of the disease.
In a study of 18 patients with MS who had severe tremors, deep brain stimulation (DBS) was tested to see if it could help. After the procedure, patients experienced less shaking, with a score decrease from 14.5 to 10, which means their tremors got better. Importantly, none of the patients had any new disease flare-ups or worsening symptoms after treatment. The overall disability level of the patients stayed about the same, showing that their condition didn't get worse. The study suggests DBS could be a safe option for managing severe tremors in MS patients.
MS patients who struggle with tremors may find this treatment helpful, as it could lead to less shaking and improved daily activities. Caregivers can feel more hopeful knowing that there are new options to help manage these symptoms. Healthcare providers can consider DBS as a safe alternative for patients who haven’t found relief with medications. Think of DBS like a new tool in a toolbox that can help fix a specific problem without breaking anything else. If you or someone you care for has MS and tremors, discussing this option with a doctor could make a positive difference in daily life.
The study involved a small group of 18 patients, which means more research is needed to see if these results apply to everyone with MS. While no new flare-ups were reported, this doesn’t guarantee that everyone will have the same experience. It’s important for patients to discuss all possible risks and benefits with their healthcare provider before considering DBS.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.